x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Neuroscience Podcast

Decera Clinical Education

Updates on new data and best practices in patient care across a wide variety of psychiatric and neurological illnesses from Decera Clinical Education. Gain a deeper understanding and practical clinical insights on topics ranging from bipolar depression to Parkinson’s disease psychosis. Select episodes available for CME/CE credit.

education courses

All Episodes

00:20:44

Tardive Dyskinesia Etiology: Risks and Considerations

Decera Clinical Education Neuroscience Podcast ·

2022/12/29

In this episode, Christoph U. Correll, MD, and John M. Kane, MD, discuss the various etiologies of tardive dyskinesia (TD). Although most healthcare professionals are aware of the risk for TD that comes with first- and second-generation antipsychotic use, there is less awareness around other modifiable and unmodifiable factors that increase risk for TD development. Some modifiable risks include metoclopramide use, anticholinergic use, and substance use disorder; unmodifiable risks include older age

en

00:24:05

Bipolar Disorder Research to Look For in 2023

Decera Clinical Education Neuroscience Podcast ·

2022/12/07

In this episode, Greg W. Mattingly, MD, and Vladimir Maletic, MD, have a conversation about the ongoing bipolar disorder research and developments expected to have an impact in the coming year. They elaborate on the various neurotransmitters being investigated and how this research might change the future of patient care. From investigating new mechanisms of action to increased uptake of more novel therapeutics such as esketamine and neuromodulation, there is a lot to look forward to. As they note

en

00:22:48

Answering Your Questions About Tardive Dyskinesia

Decera Clinical Education Neuroscience Podcast ·

2022/12/06

Get answers to the questions that you and your colleagues have asked! In this episode, Jonathan M. Meyer, MD; Leslie Citrome, MD, MPH; and Stuart Isaacson, MD, provide answers to audience questions that were submitted at recent CCO Psychiatry meetings. Their thoughtful responses cover your questions on screening, communicating with patients, medication management, and more. Moderators Rajesh Pahwa, MD; Charles DeBattista, DMH, MD; and Greg W. Mattingly, MD, provide complementary commentary

en

00:29:50

Symptom Management in Bipolar Depression: Realistic...

Decera Clinical Education Neuroscience Podcast ·

2022/11/01

In this episode, Joseph F. Goldberg, MD, and Roger McIntyre, MD, FRCPC, shed light on the symptom improvement timeline in bipolar depression. This is a topic made more complex when factoring in individual patient characteristics and comorbidities, but the 2 experts have astute insights on how to tailor a management plan based on such factors. They cover symptom management and improvement from a variety of angles, including evaluating improvement in functionality and mood, guidance on follow-up and

en

00:22:37

A Comprehensive Look at Tardive Dyskinesia Management

Decera Clinical Education Neuroscience Podcast ·

2022/10/28

In this podcast episode, Robert O. Cotes, MD, and Jonathan M. Meyer, MD, discuss tardive dyskinesia from identification to follow-up and ongoing management. They provide valuable insights on pharmacologic options to both consider and avoid to optimize outcomes in patients with tardive dyskinesia, including a focus on clinical strategies for use of VMAT2 inhibitors.Presenters:Robert O. Cotes, MDAssociate ProfessorDepartment of Psychiatry and Behavioral SciencesEmory University School of

en

00:35:49

Pharmacologic Management Options for Patients With...

Decera Clinical Education Neuroscience Podcast ·

2022/10/17

In this podcast episode, Diana O. Perkins, MD, MPH, and Rajiv Tandon, MD, provide a wealth of information on VMAT2 inhibitors and their use for tardive dyskinesia (TD) management. Their discussion includes information on VMAT2 inhibitor emergence in clinical practice, mechanism of action, adverse event profiles, insurance coverage, and strategies for initiation and titration. In addition to VMAT2 inhibitors, the experts touch on off-label options for TD management and their place in the TD

en

00:25:22

Treatment Considerations Across the Bipolar...

Decera Clinical Education Neuroscience Podcast ·

2022/10/06

In this episode, Greg W. Mattingly, MD, and Vladimir Maletic, MD, share their thoughts on treatment strategies across the bipolar depression spectrum. They begin by talking about their stance on treating bipolar with comorbidities with a holistic vs stepwise approach and discuss what strategies they would consider for a patient not yet diagnosed with but who is at risk of developing bipolar depression. In addition, they discuss the concept of phase-specific treatment, considerations for

en

00:16:54

Patient Interview: Living With Tardive Dyskinesia

Decera Clinical Education Neuroscience Podcast ·

2022/09/28

In this podcast episode on tardive dyskinesia (TD), Joseph P. McEvoy, MD, interviews Leslie, a patient who was diagnosed with TD 10 years ago. She describes her journey to an accurate diagnosis, the impact that TD has on her daily life, and her advice for patients and providers affected by TD.Presenters:Joseph P. McEvoy MDProfessorPsychiatry and Health BehaviorPsychiatristAugusta UniversityAugusta, GeorgiaLeslieThis content is based on a CE/CME program supported by independent educational grants

en

00:29:49

Diagnosis Detective: Accurately Identifying Bipolar...

Decera Clinical Education Neuroscience Podcast ·

2022/09/02

In this episode, Greg W. Mattingly, MD, and Vladimir Maletic, MD, have a conversation about the complexities of accurately diagnosing bipolar depression. Bipolar depression can be difficult to differentiate from other psychiatric conditions, such as unipolar depression, depression with mixed features, ADHD, PTSD, and anxiety. This differential is made more challenging in that patients with bipolar depression often have psychiatric comorbidities with overlapping symptomology. Listen as the 2

en

00:16:18

Answering Your Questions About Bipolar Depression

Decera Clinical Education Neuroscience Podcast ·

2022/08/01

Get answers to the questions that you and your colleagues have asked! In this episode, Charles DeBattista, MD, provides answers to audience questions that were submitted at 2 recent Psychiatry Update meetings. His thoughtful responses cover your questions on differential diagnosis, initiating pharmacotherapy, medication management, and more. Moderators Amber Hoberg, PMHNP, and Greg W. Mattingly, MD, provide complementary commentary throughout the Q&A session, adding interprofessional perspective to

en

00:23:11

How Can We Screen for and Identify Tardive Dyskinesia?

Decera Clinical Education Neuroscience Podcast ·

2022/07/11

In this first of 6 podcast episodes on tardive dyskinesia (TD), Drs Greg W. Mattingly and Jonathan M. Meyer have a discussion on identifying TD in clinical practice—including how to effectively screen patients during telehealth appointments. They cover who should be screened and how often, informal vs formal screening, and the valuable insight that family/caregiver reports can provide in the identification process. Additional conversation sheds light on differentiating TD from other movement

en

00:19:16

A Comprehensive Overview of the Bipolar Spectrum

Decera Clinical Education Neuroscience Podcast ·

2022/07/07

In this episode, Drs Greg W. Mattingly and Charles DeBattista have a conversation about the history and features of the bipolar spectrum. Because patients can present in mixed vignettes, diagnosis of bipolar depression can be challenging. The experts offer insight on when to hold a suspicion for bipolar depression, as well as common presentations they have seen over their years in clinical practice. The conversation then progresses to potential “triggers” of bipolar depression and culminates with a

en

00:27:13

The Functional and Social Impact of TD on the Lives...

Decera Clinical Education Neuroscience Podcast ·

2022/01/11

In this episode, Diana Perkins, MD, MPH, and Martha Sajatovic, MD, discuss the impact of tardive dyskinesia on social and functional domains and the benefits of proper assessment and treatment of tardive dyskinesia in improving patient quality of life in these areas.Presenters:Diana Perkins, MD, MPHProfessor of Psychiatry University of North Carolina School of MedicineChapel Hill, North Carolina Martha Sajatovic, MDProfessor of Psychiatry and NeurologyDepartments of Psychiatry and NeurologyCase

en

00:30:21

Evidence-Based Approaches to Choosing the Right...

Decera Clinical Education Neuroscience Podcast ·

2021/11/30

In this episode, Roger McIntyre, MD, FRCPC, and Sanjay Mathew, MD, discuss choosing the right treatment in bipolar depression. They review patient assessment and differential diagnosis for bipolar depression, describe various screening tools, examine evidence-based pharmacotherapies, consider the role of adjunctive antidepressants, neuromodulation, light therapy, and psychological treatments, and explore future directions in bipolar depression treatment. Presenters:Sanjay J. Mathew, MDProfessor and

en

00:26:17

Multidisciplinary Approach to Evaluation and...

Decera Clinical Education Neuroscience Podcast ·

2021/11/16

In this episode, Greg Mattingly, MD, and W. Clay Jackson, MD, DipTh, discuss who PCPs should screen for TD, adverse effects PCPs should put on their radar screen when monitoring patients on antipsychotics, how TD is different from parkinsonism, the use of anticholinergics, and which patients have an increased risk for TD when on antipsychotics. Presenters:Greg Mattingly, MDAssociate Clinical ProfessorPsychiatry, PsychopharmacologyWashington University School of MedicineSt Louis, MissouriPresidentSt

en

00:34:47

What Is the Role for Antidepressants in Bipolar...

Decera Clinical Education Neuroscience Podcast ·

2021/10/05

In this episode, Joseph Goldberg, MD, and Greg Mattingly, MD, discuss the role of antidepressants in bipolar disorder. They review use of newer antidepressants (eg, vortioxetine, vilazodone) for bipolar depression despite lack of large, formal studies for that indication, the safety/efficacy of antidepressants for bipolar II vs bipolar I, antidepressant monotherapy in bipolar II depression, ketamine/esketamine for bipolar depression, and discuss the role for an antidepressant for bipolar depression

en

00:31:31

Diagnostic Dilemmas in Differentiating Unipolar and...

Decera Clinical Education Neuroscience Podcast ·

2021/08/20

In this episode, Leslie Citrome, MD, MPH, and Manpreet K. Singh, MD, MS, discuss diagnosing unipolar vs bipolar depression. They review why it can be difficult to differentiate between unipolar and bipolar depression; which screening tools they employ, including the rapid mood screener (RMS); how to reduce chances of missing mania; and special tips for differentiating between major depressive disorder (MDD) and bipolar depression in children. Presenters:Leslie Citrome, MD, MPHClinical

en

00:31:13

Dilemmas in TD in Primary Care

Decera Clinical Education Neuroscience Podcast ·

2021/08/20

In this episode, Greg Mattingly, MD, and W. Clay Jackson, MD, DipTh , discuss how the use of antipsychotics has changed in primary care patients, how primary care physicians can screen for tardive dyskinesia (TD), and increasing needs for the primary care physician in mental health.Presenters:Greg Mattingly, MDAssociate Clinical ProfessorPsychiatry, PsychopharmacologyWashington University School of MedicineSt Louis, MissouriPresidentSt Charles Psychiatry AssociatesSt Charles, MissouriW. Clay

en

00:30:52

Relationship of EPS, Antiparkinsonian Drugs, and TD

Decera Clinical Education Neuroscience Podcast ·

2021/07/20

In this episode, John M. Kane, MD, and Rebecca S. Roma, MD, discuss clinical assessment of extrapyramidal symptoms (EPS), antiparkinsonian drugs, and tardive dyskinesia (TD). They review differentiating between TD and EPS, identify tools for diagnosing TD, and provide some important clinical pearls and evidence-based reasons for choosing different medications for treating EPS and TD.Presenters:John M. Kane, MDProfessor and ChairmanDepartment of PsychiatryDonald and Barbara Zucker School of Medicine

en

00:28:27

Diagnosing TD in Clinical Practice

Decera Clinical Education Neuroscience Podcast ·

2021/06/11

In this episode, Leslie Citrome, MD, MPH, and Joseph P. McEvoy, MD, discuss clinical assessment and diagnosis of tardive dyskinesia (TD). They review using the AIMS exam for identification of dyskinesia in patients in both the clinical setting and via telepsychiatry. They also review how often to perform the AIMS exam, how to assess the results, and why it is important.Presenters:Leslie Citrome, MD, MPHClinical ProfessorDepartment of Psychiatry and Behavioral SciencesNew York Medical

en

41 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College